{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:44:00Z","timestamp":1779205440492,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40199-018-0204-6","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T07:54:32Z","timestamp":1530086072000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014"],"prefix":"10.1007","volume":"26","author":[{"given":"Sandra","family":"Lopez-Leon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel I.","family":"Lopez-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Ruiter-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"204_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMc1504261","volume":"373","author":"M Olfson","year":"2015","unstructured":"Olfson M, Druss BG, Marcus SC. Trends in mental health care among children and adolescents. N Engl J Med. 2015;373:1079.","journal-title":"N Engl J Med"},{"key":"204_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.acap.2012.01.003","volume":"12","author":"CF Garfield","year":"2012","unstructured":"Garfield CF, Dorsey ER, Zhu S, Huskamp HA, Conti R, Dusetzina SB, et al. Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012;12:110\u20136.","journal-title":"Acad Pediatr"},{"key":"204_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10803-009-0723-6","volume":"39","author":"RE Rosenberg","year":"2009","unstructured":"Rosenberg RE, Daniels AM, Law JK, Law PA, Kaufmann WE. Trends in autism spectrum disorder diagnoses: 1994-2007. J Autism Dev Disord. 2009;39:1099\u2013111.","journal-title":"J Autism Dev Disord"},{"key":"204_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jaac.2014.04.015","volume":"53","author":"B Lorberg","year":"2014","unstructured":"Lorberg B, Robb A, Pavuluri M, Chen DT, Wilens T. Pediatric psychopharmacology: food and drug administration approval through the evidence lens. J Am Acad Child Adolesc Psychiatry. 2014;53:716\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"204_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/jama.2015.0763","volume":"313","author":"I Schmid","year":"2015","unstructured":"Schmid I, Burcu M, Zito JM. Medicaid prior authorization policies for pediatric use of antipsychotic medications. JAMA. 2015;313:966\u20138.","journal-title":"JAMA"},{"key":"204_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamapsychiatry.2013.3074","volume":"71","author":"M Olfson","year":"2014","unstructured":"Olfson M, Blanco C, Wang S, Laje G, Correll CU. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiat. 2014;71:81\u201390.","journal-title":"JAMA Psychiat"},{"key":"204_CR7","unstructured":"Hansen L, Chang S. Health research data for the real world: the Marketscan databases. 1-12-0017. Ref Type: Internet Communication."},{"key":"204_CR8","volume-title":"Nonparametric statistical methods for complete and censored data","author":"MMRD Desu","year":"2004","unstructured":"Desu MM RD: Nonparametric statistical methods for complete and censored data. 2004."},{"key":"204_CR9","unstructured":"Rothman KJ, Greenland S, Lash TL: Applications of stratified analysis methods. In Modern Epidemiology. 3rd edition. Edited by Lippincott W&W. Philadelphia, PA; 2008."},{"key":"204_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1176\/ps.2008.59.10.1162","volume":"59","author":"R Constantine","year":"2008","unstructured":"Constantine R, Tandon R. Changing trends in pediatric antipsychotic use in Florida's Medicaid program. Psychiatr Serv. 2008;59:1162\u20138.","journal-title":"Psychiatr Serv"},{"key":"204_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12888-016-0716-x","volume":"16","author":"I Hartz","year":"2016","unstructured":"Hartz I, Skurtveit S, Steffenak AK, Karlstad O, Handal M. Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study. BMC Psychiatry. 2016;16:12.","journal-title":"BMC Psychiatry"},{"key":"204_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/cap.2014.0057","volume":"25","author":"WD Lohr","year":"2015","unstructured":"Lohr WD, Chowning RT, Stevenson MD, Williams PG. Trends in atypical antipsychotics prescribed to children six years of age or less on Medicaid in Kentucky. J Child Adolesc Psychopharmacol. 2015;25:440\u20133.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"204_CR13","doi-asserted-by":"publisher","first-page":"e20161878","DOI":"10.1542\/peds.2016-1878","volume":"138","author":"R Mojtabai","year":"2016","unstructured":"Mojtabai R, Olfson M, Han B. National Trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics. 2016;138:e20161878.","journal-title":"Pediatrics"},{"key":"204_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States. JAMA Psychiatry. 2015;72:867\u201374.","journal-title":"JAMA Psychiatry"},{"key":"204_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ambp.2005.11.002","volume":"6","author":"WO Cooper","year":"2006","unstructured":"Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA. Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr. 2006;6:79\u201383.","journal-title":"Ambul Pediatr"},{"key":"204_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/cap.1997.7.267","volume":"7","author":"DJ Safer","year":"1997","unstructured":"Safer DJ. Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s. J Child Adolesc Psychopharmacol. 1997;7:267\u201374.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"204_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","volume":"157","author":"JM Zito","year":"2003","unstructured":"Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17\u201325.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"204_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1542\/peds.2011-2654","volume":"128","author":"M Wolraich","year":"2011","unstructured":"Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007\u201322.","journal-title":"Pediatrics"},{"key":"204_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1176\/appi.ps.201200147","volume":"64","author":"R Kornfield","year":"2013","unstructured":"Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, et al. Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv. 2013;64:339\u201346.","journal-title":"Psychiatr Serv"},{"key":"204_CR20","unstructured":"European Union. Referrals document: Questions and answers on the review of medicines containing methylphenidate. EMA. 2009. (Accessed January, 6, 2017 at \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Methylphenidate_31\/WC500011125.pdf\n                    \n                  )"},{"key":"204_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4065\/82.4.518","volume":"82","author":"TW Lineberry","year":"2007","unstructured":"Lineberry TW, Bostwick JM, Beebe TJ, Decker PA. Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box. Mayo Clin Proc. 2007;82:518\u201320.","journal-title":"Mayo Clin Proc"},{"key":"204_CR22","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1056\/NEJMp1408480","volume":"371","author":"RA Friedman","year":"2014","unstructured":"Friedman RA. Antidepressants' black-box warning--10 years later. N Engl J Med. 2014;371:1666\u20138.","journal-title":"N Engl J Med"},{"key":"204_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3596","volume":"348","author":"CY Lu","year":"2014","unstructured":"Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, et al. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ. 2014;348:g3596.","journal-title":"BMJ"},{"key":"204_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/diacare.27.2.596","volume":"27","author":"Consensus development conference on antipsychotic drugs and obesity and diabetes","year":"2004","unstructured":"Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596\u2013601.","journal-title":"Diabetes Care"},{"key":"204_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S0033291709990407","volume":"40","author":"I Tarricone","year":"2010","unstructured":"Tarricone I, Ferrari GB, Serretti A, Grieco D, Berardi D. Weight gain in antipsychotic-naive patients: a review and meta-analysis. Psychol Med. 2010;40:187\u2013200.","journal-title":"Psychol Med"},{"key":"204_CR26","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2009.1549","volume":"302","author":"CU Correll","year":"2009","unstructured":"Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302:1765\u201373.","journal-title":"JAMA"},{"key":"204_CR27","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1001\/jama.2013.281140","volume":"310","author":"BM Kuehn","year":"2013","unstructured":"Kuehn BM. APA targets unnecessary antipsychotic use. JAMA. 2013;310:1909\u201310.","journal-title":"JAMA"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40199-018-0204-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-018-0204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-018-0204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T20:48:13Z","timestamp":1568666893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40199-018-0204-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1007\/s40199-018-0204-6","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]},"assertion":[{"value":"27 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"An ethics committee approved the data collected. We received unidentified data and all data is presented in aggregated form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}